the antitumoral activity and toxicity of a new daunorubicin analog ( 4-demethoxydaunorubicin , imi 30 , idarubicin ) was tested in 20 consecutive patients with non-small cell lung cancer mostly pretreated with chemotherapy .
C0011015
daunorubicin
C0020789
idarubicin